Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 20.61% Profit – QuantWave Analysis

May 03, 2023
ELI LILLY AND COMPANY stock has successfully reached the price target forecast set by QuantWave, resulting in a profit of 20.61% for investors. The forecast signal date was December 13, 2022, with a price of 350.76 $. The predicted direction was long, and on May 3, 2023, the stock hit the target price of 423.05 $.

This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The successful forecast for ELI LILLY AND COMPANY demonstrates the platform's ability to provide valuable insights for investors looking to make informed decisions in the market.

The stock's movement can be attributed to several factors, including strong financial performance, positive industry trends, and market sentiment towards the healthcare sector. ELI LILLY AND COMPANY's innovative products and strategic initiatives have also contributed to its growth, leading to a favorable outlook among investors.

QuantWave is an automated forecasting platform that offers predictions for a wide range of stocks, presenting opportunities for potential profits. For investors seeking to delve deeper into the investment strategy behind QuantWave, QuantSchool provides comprehensive educational resources on maximizing returns using the forecasting system. QuantSchool's professional investment framework unveils the key principles for generating consistent income through QuantWave's analytics.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


UNHJuly 30, 2024UNITEDHEALTH GROUP INCORPORATED Hits 7.86% Profit Target as Forecasted by QuantWave  ~2 min.

UNITEDHEALTH GROUP INCORPORATED (NYSE: UNH) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 7.86% for investors....


BMYNovember 11, 2024BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 13.38% Profit  ~1 min.

On October 22, 2024, QuantWave issued a forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price target of $58.53, predicting a long position. The stock was trading at $51....


UNHJuly 16, 2024UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast on QuantWave, Generating 10.16% Profit  ~1 min.

UNITEDHEALTH GROUP INCORPORATED has successfully reached the price target forecast set by QuantWave, leading to a profit of 10.16%. The forecast signal date was 2024-07-02, with a price of 492....


UNHApril 21, 2025UNITEDHEALTH GROUP INCORPORATED Hits 10.66% Profit Target Forecast by QuantWave  ~1 min.

UNITEDHEALTH GROUP INCORPORATED has successfully reached the price target forecasted by QuantWave, resulting in a profit of 10.66% for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target with Profit of 16.36%  ~1 min.

QuantWave, a leading automated forecasting platform, successfully predicted a profitable price movement for ASTRAZENECA PLC stock....